AHPA staff and members present at regulatory summit, USP, FDA-CFSAN and more

Recent AHPA Advocacy

AHPA staff and members present at regulatory summit, USP, FDA-CFSAN and more

AHPA provides expertise in hemp-CBD, regulatory initiatives, pesticide residues, NDIs and food allergens

Published: Tuesday, May 21, 2019

AHPA staff and members presented at several supplement events last week to represent AHPA member interests and provide expert insights into issues impacting the industry.

Dietary Supplement Regulatory Summit

AHPA President Michael McGuffin presented on a panel of FDA officials and supplement association leaders at the Dietary Supplement Regulatory Summit. Many members attended this annual collaboration between AHPA, the Council for Responsible Nutrition (CRN), the Consumer Healthcare Products Association (CHPA), the Natural Products Association (NPA) and the United Natural Products Alliance (UNPA). The full-day regulatory summit featured updates and insights from FDA and industry regulatory experts.

Media coverage:

FDA-CFSAN Public Meeting: Responsible Innovation in Dietary Supplements

McGuffin also presented on New Dietary Ingredient Notification (NDIN) requirements and exceptions at the FDA-CFSAN Public Meeting: Responsible Innovation in Dietary Supplements. A video of McGuffin's presentation is available online.

Presentation:

Media coverage:

USP Dietary Supplement Stakeholder Forum

McGuffin and AHPA Chief Science Officer Holly E. Johnson, Ph.D., provided expert insights at the U.S. Pharmacopeial Convention (USP) Dietary Supplement Stakeholder Forum held on Wednesday. The event also featured presentations by AHPA Board Member Aaron Secrist from NOW Foods and Duffy MacKay, Ph.D., from AHPA member company CV Sciences. AHPA provided input on a host of issues, including hemp, regulatory initiatives, pesticides and food allergens.

Presentation:

3rd SoCal Dietary Supplement Consortium

McGuffin presented on Friday at the 3rd SoCal Dietary Supplement Consortium on the 2018 Farm Bill and how it impacts hemp and hemp-derived products, including cannabidiol (CBD)

Presentation:

U.S. Hemp Authority Meeting

Dr. Johnson also attended a meeting of the Hemp Authority on Friday to provide expert insights into a certification program aimed at standardizing quality control in the hemp industry post-Farm Bill and recognizing companies that have taken steps to produce safe and accurately labeled hemp-derived products. The Hemp Authority is working to revise this program based on a broad review by interested parties.
Print

2019 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.